Derms on Drugs

The Derms on Drugs give the definitive answer to the age old question:  What came first, the chicken or the egg?  You'll have to listen to find out.   What's a Mazotti Reaction and why do you care? How do JAK inhibitors compare to dupilumab for treating prurigo nodularis? What's a cheap, easy, safe, effective treatment for palmoplantar pustulosis? Can a steroid nasal spray help for Chr...

Get ready for a no-nonsense tour-de-force of practical application in the latest derm literature. Pipeline drugs, new approvals, brand names, generics—and HS data you’re better off ignoring (we’ll tell you why).   In this episode: ·        Leqselvi : the newest JAK for alopecia areata—actually different, or more of the same? ·        HS & spondyloarthritis : are you screening… should you be? ·...

Listening this week could save your life (well, at least your kidneys).  Find out what common ingredient in keratin treatments you (and your friends, family and patients) NEED to avoid.  But there's a lot more than that packed into this week's episode.  As always, the Derms on Drugs bring the goods on the latest questions that the literature is answering: -Is isotretinoin making kids short...

Admit it—bad hair days are the worst. Now imagine every day is one. Alopecia’s psychological impact is  way  deeper (and more surprising) than most people think. This week, the Derms on Drugs sit down with Harvard’s Dr. Maryanne Makredes Senna to unpack the mental side of AA—and then dive into what to do when a JAK inhibitor just… doesn’t JAK. As always, we’re answering the questions you didn’t ev...

This week, the Derms on Drugs are back with another literature speed-run—think  3D chess meets derm nerd nirvana. We’re answering questions you didn’t even know you had (and a few you wish you didn’t). Here’s what we’re tackling: Do herbal supplements  turn up  dermatomyositis? Can biologics cut down on blood clots in HS? Wait… does  Claritin supercharge isotretinoin ? Is Sotyktu stirring up rosac...

The Derms on Drugs are joined by Dr. Crystal Aguh from Johns Hopkins for an AMAZING discussion on central centrifugal scarring alopecia.  From uber practical, cheap, safe, effective treatment approaches to deep science on what is happening in this disease, listen this week and you'll be an expert - how to talk to these patients, the baseline treatments everybody should be on, when to get more...

Join us this week as the Derms on Drugs crew discusses the latest in the Dermatology literature.  Topics for this episode include:   - Cutaneous vasculitis of the skin (it’s a Chapel Hill thing) - Ozempic face, butt, and body - TAC injections for AA – what concentration do you use? - Does the MERLIN study deserve its magical name? - Are systemic JAK inhibitors the answer for vitiligo? - And everyo...

You don't see a lot of kids with psoriasis, but when you do it can be a big challenge, especially if it's bad and they need a systemic.  The Derms on Drugs are coming to the rescue!  We'll have a special guest - Dr. Doug Kress (who was heavily involved in training all three of the Derms on Drugs) who has enormous experience treating pediatric psoriasis.  We'll get into all the stuf...

Brought to you by Scholars In Medicine  The Derms on Drugs take on the latest, greatest and coolest stuff from the Derm literature.  Quite honestly, there was some stuff this week that just seems crazy and that you won't want to miss.  Join us as we discuss questions like:    -Do tattoos protect people against melanoma?  -What cheap, easy topical works great for fissures in hand eczema?  -Is D...

Join the Derms on Drugs and Dr. Shanthi Narla as we dive into the world of obesity, GLP-1s and dermatology.  Whatever you think about all of these topics, we promise that your patients are hearing about them, reading about them and will be asking about them.  Specifically, we'll get into the latest data about how GLP-1s affect diseases like psoriasis, hidradenitis suppurativa and atopic dermat...

Join the Derms on Drugs as we slice and dice the latest dermatology literature.  We've got stuff that will change what you do next week, answers for uncommon but challenging diseases and the latest updates on the pharma pipeline.  We'll answer burning questions, like: -When is the best time to start niacinamide for skin cancer prevention? -Which drugs work the best for the itch of atopic d...

Join the Derms on Drugs as we slice and dice the latest dermatology literature.  We've got stuff that will change what you do next week, answers for uncommon but challenging diseases and the latest updates on the pharma pipeline.  We'll answer burning questions, like: -When is the best time to start niacinamide for skin cancer prevention? -Which drugs work the best for the itch of atopic d...

Ever wonder if you can trust those network meta-analyses (NMAs) flooding dermatology journals? Join the Derms on Drugs and University of Toronto expert Dr. Aaron Drucker for a critical deep dive into NMAs—what they are, how they work, and whether dermatologists should rely on them for treatment decisions. NMAs promise head-to-head comparisons for drugs without having to do a head-to-head trial, es...

Welcome back to  Derms on Drugs ! Today we’re cracking open a six-pack—not IPAs, but papers. We’ve got polyomavirus antibodies sneaking in as early markers for Merkel cell recurrence, collagen supplements promising to smooth wrinkles or just make your bank accounts smaller, and ruxolitinib cream stepping up for the disaster that is chronic hand eczema. But wait—there’s more! Isotretinoin is back,...

Join the Derms on Drugs and Dr. Marc Serota (who is triple boarded in dermatology, allergy and pediatrics) to find out the latest on how to think about the causes of chronic spontaneous urticaria - it can be autoimmune, it can literally be an "allergy to yourself" or it can be neither of the above.  Crucially, there are clinical clues to which one it is, and if you can figure out which o...

Get ahead of the curve with Derms on Drugs as we break down the most exciting new dermatology research! This week features game-changing studies including an oral probiotic with stunning results for atopic dermatitis, JAK inhibitors for bullous pemphigoid, and IL-23 inhibitors tackling guttate psoriasis. Plus, we dive deep into: Dermoscopy advances for managing longitudinal melanonychia If failing...

Stay at the forefront of dermatology with the Derms on Drugs and their special guest Dr. Scott Drew! This episode is a rapid-fire roundup of the latest journal pearls-perfect for busy practitioners looking to keep up with the latest evidence in the literature. We cover: Can moisturizing infants prevent atopic dermatitis? New sunscreen ingredients headed for the US market Insights from lichenoid er...

Older systemic drugs aren’t just relics—they’re critical tools for dermatologists tackling all kinds of medical diseases - whether we're talking about patients who can't access (or don't respond adequately) to our highly effective FDA approved drugs for psoriasis, atopic dermatitis, alopecia areata, hidradenitis or about patients with diseases that don't have an extremely effective FDA approved dr...

The Derms on Drugs take on the latest, greatest and coolest stuff from the Derm literature.  Quite honestly, there was some stuff this week that just seems crazy and that you won't want to miss.  Join us as we discuss questions like: -Do tattoos protect people against melanoma? -What cheap, easy topical works great for fissures in hand eczema? -Is Dupixent safe in pregnancy? -Are tinted sunscreens...

Older systemic drugs aren’t just relics—they’re critical tools for dermatologists tackling tough diseases like lichen planus, granuloma annulare, psoriasis, atopic dermatitis, and alopecia areata, especially when FDA-approved options fall short or are inaccessible. Join Derms on Drugs and guest expert Dr. Scott Drew as we share practical pearls for using methotrexate, mycophenolate, cyclosporine,...

Today on Derms on Drugs we’ve got the fabulous Dr. Heather Woolery-Lloyd with us, and yes—we’re talking sunscreens. Don’t roll your eyes, because we’re going way past “SPF 30 or 50?” into the good stuff: how these lotions and potions actually work, which myths need to finally get buried, and why tinted sunscreens aren’t just makeup but legit medicine for skin of color. We’ll also dish on the brand...

Welcome back to another episode of Derms on Drugs—where we prescribe only the  highest yield  practical pearls (and zero prior authorizations are ever required). If dermatology conferences make you yawn but a six-pack of journal articles gets your heart racing, you’re definitely in the right clinic! What’s on Tap in Our 6 Pack Episode? Today, we’re serving up a refreshing six-pack— no ice needed ,...

Welcome to another episode of  Derms on Drugs , where we peel back the layers on the latest in dermatology therapeutics. Today, we’re thrilled to have Dr. Donna Culton join us for a deep dive into the world of bullous pemphigoidIn this episode we: Review three of the hottest papers on bullous pemphigoid, dissecting the latest evidence with our signature blend of rigor and irreverence. Break down t...

Welcome to the first-ever Derms on Drugs Debate! Our brave hosts tackle three of the hottest—and most controversial—questions in the field: Castle Gene Expression Profile in Melanoma: Should dermatologists use it for almost every melanoma, just those “close to 1 mm,” or leave it to the oncologists? Zoryve, VTAMA and Opzelura: All great drugs, but if you could only keep one, which would it be? Our...

Ready to level up your medical dermatology game? This week, Derms on Drugs tackles the toughest questions and latest controversies in serious derm—served with our signature practical, no-nonsense style with a big dose of humor. We break down the newest literature and answer: Does immunotherapy really help with high-risk squamous cell carcinoma? Are pemphigus patients getting more rituximab than th...